Bondi Sands Fragrance Free SPF 30 Sunscreen Lotion

Bondi Sands Fragrance Free SPF 30 Sunscreen by

Drug Labeling and Warnings

Bondi Sands Fragrance Free SPF 30 Sunscreen by is a Otc medication manufactured, distributed, or labeled by Baxter Laboratories Pty. Ltd.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

BONDI SANDS FRAGRANCE FREE SPF 30 SUNSCREEN- avobenzone, homosalate, octisalate, octocrylene lotion 
Baxter Laboratories Pty. Ltd.

----------

Bondi Sands Fragrance Free SPF 30 Sunscreen Lotion

Active Ingredients

Avobenzone 3%, Homosalate 10%, Octisalate 5%, Octocrylene 8%

Purpose

Sunscreen

Uses

• Helps prevent sunburn
• If used as directed with other sun protections measures (see Directions), decreases the risk of cancer and early skin aging caused by the sun.
• Retains SPF after 80 minutes of activity in the water.

Warnings

For external use only

Do not use on damaged or broken skin.

Stop use and ask a doctor if rash occurs.

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

When using this product

keep out of eyes. Rinse with water to remove.

Directions

• Apply liberally 15 minutes before sun exposure.
• Reapply:
• after 80 minutes of swimming or sweating
• immediately after towel drying
• at least every 2 hours
• Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including:
• Limit time in the sun, especially from 10 a.m.- 2 p.m.
• Wear long-sleeved shirts, pants, hats, and sunglasses.
• Children under 6 months: Ask a doctor.

Other information

• Protect the product in this container from excessive heat and direct sun.
• You may report a serious adverse reaction to 888-266-0772; Monday – Friday, 9 am – 5 pm.

Inactive Ingredients

Water/Aqua/Eau, Beeswax/Cera Alba/Cire d'abeille, Aloe Barbadensis Leaf Juice, Isopropyl Palmitate, Cetearyl Alcohol, Cyclopentasiloxane, Cyclohexasiloxane, Ceteareth-20, Hydroxyacetophenone, Carbomer, Benzyl Alcohol, Saccharide Isomerate, Phenoxyethanol, Sodium Stearoyl Glutamate, Triethanolamine, Tocopheryl Acetate, Sodium Chloride, Citric Acid.

Questions?

888-266-0772 or visit bondisands.com

Product Packaging

bondi sands

The Australian tan

BROAD SPECTRUM

SPF 30

VERY WATER RESISTANT 80 MINUTES

FRAGRANCE FREE

SUNSCREEN LOTION

REEF FRIENDLY

72HY HYDRATION

SUITABLE FOR SENSITIVE SKIN

Australian Made

5.07 FL. OZ. (150mL)

BONDI SANDS FRAGRANCE FREE SPF 30 SUNSCREEN 
avobenzone, homosalate, octisalate, octocrylene lotion

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 70157-011
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
AVOBENZONE (UNII: G63QQF2NOX) (AVOBENZONE - UNII:G63QQF2NOX)	AVOBENZONE	30 mg  in 1 mL
OCTOCRYLENE (UNII: 5A68WGF6WM) (OCTOCRYLENE - UNII:5A68WGF6WM)	OCTOCRYLENE	80 mg  in 1 mL
HOMOSALATE (UNII: V06SV4M95S) (HOMOSALATE - UNII:V06SV4M95S)	HOMOSALATE	100 mg  in 1 mL
OCTISALATE (UNII: 4X49Y0596W) (OCTISALATE - UNII:4X49Y0596W)	OCTISALATE	50 mg  in 1 mL

Inactive Ingredients
Ingredient Name	Strength
PHENOXYETHANOL (UNII: HIE492ZZ3T)
SODIUM STEAROYL GLUTAMATE (UNII: 65A9F4P024)
SACCHARIDE ISOMERATE (UNII: W8K377W98I)
BENZYL ALCOHOL (UNII: LKG8494WBH)
CARBOMER HOMOPOLYMER, UNSPECIFIED TYPE (UNII: 0A5MM307FC)
WATER (UNII: 059QF0KO0R)
ALOE VERA LEAF (UNII: ZY81Z83H0X)
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)
ISOPROPYL PALMITATE (UNII: 8CRQ2TH63M)
CETOSTEARYL ALCOHOL (UNII: 2DMT128M1S)
CYCLOMETHICONE 5 (UNII: 0THT5PCI0R)
CYCLOMETHICONE 6 (UNII: XHK3U310BA)
POLYOXYL 20 CETOSTEARYL ETHER (UNII: YRC528SWUY)
HYDROXYACETOPHENONE (UNII: G1L3HT4CMH)
YELLOW WAX (UNII: 2ZA36H0S2V)
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)
TROLAMINE (UNII: 9O3K93S3TK)
SODIUM CHLORIDE (UNII: 451W47IQ8X)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 70157-011-01	150 mL in 1 TUBE; Type 0: Not a Combination Product	01/01/2021	01/01/2021

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M020	01/01/2021	01/01/2021

Labeler - Baxter Laboratories Pty. Ltd. (740537709)

Revised: 10/2025

Document Id: 422a98a7-230a-0270-e063-6294a90aa3c1

34390-5

Set id: 0fb4e1a5-ad35-0c0d-e063-6394a90a6721

Version: 2

Effective Time: 20251027